Winiarski Piotr, Lewandowski Artur, Greczka Grażyna, Banaszewski Jacek, Klimza Hanna, Wierzbicka Małgorzata
Department of Otolaryngology, Otolaryngological Oncology and Maxillofacial Surgery, Jan Biziel Second University Hospital, Bydgoszcz, Poland.
Department of Otolaryngology and Oncological Laryngology, Poznan University of Medical Sciences, Poznan, Poland.
Lasers Surg Med. 2018 Apr;50(4):311-318. doi: 10.1002/lsm.22759. Epub 2017 Nov 14.
The main goal was to compare the clinical data of patients with T1 and T2 glottic cancer treated with CO transoral laser microlaryngoscopy (TLM) in the Tertiary Referral University Department of Otolaryngology, Head Neck Surgery, Poznan and the local Department of Otolaryngology, Oncology and Maxillofacial Surgery, Bydgoszcz.
Unified databases for the 7-year period January 2005-December 2011 were created to compare these two cohorts. The database contained 341 patients: 231 from the tertiary center and 110 from the local department, of which 298 (87%) were men, and 43 (13%) were women.
Cordectomy type I-IV was performed in 250 (73%) patients, cordectomy type V-VI in 84 (25%) patients, and cordectomy enlarged to epiglottic petiole in 7 (2%) patients. Local recurrence was observed in 96 (28%) cases. Among these cases, 81 (87.5%) patients had salvage surgery: 43 re-cordectomy, 10 open partial laryngectomy, and 28 total laryngectomy. The outcomes for the whole cohort, Tertiary Referral Center and Local Department respectively were as follows: larynx preservation rate was 91.8%, 93.6%, and 88%; 3-year disease specific survival was 97.4%, 97.9%, and 93.3%; 3-year overall survival was 93.5%, 96.6%, and 85.5%; 5-year disease specific survival was 95.2%, 95.2%, and 96.3%; and 5-year overall survival was 84.5%, 88.7%, and 76%, respectively.
Comparison of the cohorts showed that outcomes of primary treatment were similar but there were noticeable differences in salvage treatment efficacy, favoring patients from the Tertiary Referral Center. Lasers Surg. Med. 50:311-318, 2018. © 2017 Wiley Periodicals, Inc.
主要目的是比较在波兹南的三级转诊大学耳鼻咽喉头颈外科和比得哥什的当地耳鼻咽喉头颈外科、肿瘤与颌面外科,接受一氧化碳经口激光显微喉手术(TLM)治疗的T1和T2声门癌患者的临床数据。
创建了2005年1月至2011年12月这7年期间的统一数据库,以比较这两个队列。该数据库包含341例患者:231例来自三级中心,110例来自当地科室,其中298例(87%)为男性,43例(13%)为女性。
250例(73%)患者进行了I-IV型声带切除术,84例(25%)患者进行了V-VI型声带切除术,7例(2%)患者的声带切除术扩大至会厌柄。96例(28%)病例观察到局部复发。在这些病例中,81例(87.5%)患者接受了挽救性手术:43例再次进行声带切除术,10例进行开放性部分喉切除术,28例进行全喉切除术。整个队列、三级转诊中心和当地科室的结果分别如下:喉保留率为91.8%、93.6%和88%;3年疾病特异性生存率为97.4%、97.9%和93.3%;3年总生存率为93.5%、96.6%和85.5%;5年疾病特异性生存率为95.2%、95.2%和96.3%;5年总生存率分别为84.5%、88.7%和76%。
队列比较显示,初始治疗的结果相似,但挽救性治疗效果存在显著差异,三级转诊中心的患者更具优势。《激光外科与医学》50:311 - 318, 2018。© 2017威利期刊公司